Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: Barclays, Nomura Cut Unilever Price Target

Tue, 01st Oct 2013 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:
----------
FTSE 100
----------
PANMURE GORDON REPLACES SHIRE WITH HIKMA AS 'TOP PICK'
----------
MORGAN STANLEY RAISES BT GROUP PRICE TARGET TO 350 (310) PENCE - 'EQUAL-WEIGHT'
----------
Jefferies reiterates Buy rating for Kingfisher and increases its target price to 440p, from 400p
----------
HSBC RAISES VODAFONE PRICE TARGET TO 255 (230) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES VODAFONE PRICE TARGET TO 255 (230) PENCE - 'OVERWEIGHT'
----------
NOMURA CUTS UNILEVER NV PRICE TARGET TO 32.25 (34.30) EUR - 'BUY'
----------
BARCLAYS CUTS UNILEVER NV PRICE TARGET TO 35 (36) EUR - 'OVERWEIGHT'
----------
TRADERS: SOCGEN CUTS BRITISH LAND TO 'HOLD' ('BUY')
----------
S&P CAPITAL IQ CUTS RIO TINTO TO 'SELL' ('BUY') - PRICE TARGET 2,700 (3,800) PENCE
----------
FTSE 250
----------
PANMURE CUTS LADBROKES PRICE TARGET TO 171 (188) PENCE - 'HOLD'
----------
PANMURE RAISES AVEVA GROUP PRICE TARGET TO 2374 (2174) PENCE - 'HOLD'
----------
HSBC RAISES STAGECOACH TO 'NEUTRAL' ('UNDERWEIGHT') - TARGET 325 (305) PENCE
----------
HSBC RAISES NATIONAL EXPRESS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
Goldman Sachs CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 1180 (1190) PENCE - 'NEUTRAL'
----------
HSBC RAISES FIRSTGROUP PRICE TARGET TO 115 (110) PENCE - 'NEUTRAL'
----------
HSBC RAISES GO-AHEAD GROUP PRICE TARGET TO 1810 (1635) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES HAYS PRICE TARGET TO 105 (90) PENCE - 'HOLD'
----------
TRADERS: SOCGEN CUTS SEGRO TO 'HOLD' ('BUY')
----------
TRADERS: SOCGEN CUTS DERWENT TO 'HOLD' ('BUY')
----------
NOMURA CUTS LADBROKES PRICE TARGET TO 145 (165) PENCE - 'REDUCE'
----------
ALL-SHARE AND AIM
----------
WH Ireland raises Findel target price to 310p from 250p, reiterating a Buy rating
----------
CS CUTS AFRICAN MINERALS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 280 (350) PENCE
----------
PANMURE RAISES INNOVATION GROUP PRICE TARGET TO 41 (38) PENCE - 'BUY'
----------
CANACCORD RAISES HELLERMANNTYTON PRICE TARGET TO 295 (280) PENCE - 'BUY'
----------
CANACCORD CUTS IOMART GROUP TO 'HOLD' ('BUY') - TARGET 300 PENCE
----------
NUMIS RAISES RENEW HOLDINGS PRICE TARGET TO 185 (148) PENCE - 'BUY'
----------
JPM RAISES NEW WORLD RESOURCES PRICE TARGET TO 59 (50) PENCE - 'UNDERWEIGHT'
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.